Lot 005-2026
Quick Laboratory Summary
A concise overview of the reported laboratory results for the current production lot.
- Lot identification
- Selected reported results
- Testing summary
- Suitable for quick review
Welcome to our store
BAC Colombia Product Documentation
BAC Colombia publishes lot-specific laboratory documentation for its bacteriostatic water products. Representative samples from each production lot are submitted to an independent third-party laboratory for analytical and microbiological testing before the lot is released for sale.
Every new production lot receives its own supporting documentation. As new lots become available, this page is updated with the corresponding results, Certificates of Analysis, and laboratory reports.
Current Production Lot
The documentation for this production lot applies to BAC Colombia 3 mL, 10 mL, and 30 mL presentations filled from the same production lot.
Lot 005-2026
The following summary presents selected results reported for representative samples from Lot 005-2026. Complete supporting documentation is available in the full laboratory file.
| Test | Method / Reference | Reported Result | Laboratory Status |
|---|---|---|---|
| Appearance | Visual Evaluation | Clear, Colorless | Within Reported Specification |
| pH | Instrumental pH Measurement | 6.87 | Within Reported Specification |
| Benzyl Alcohol Quantification | HPLC | 9.48 mg/mL | Within Reported Specification |
| Sterility Test | USP <71> | No Growth Detected | Passed |
| Bacterial Endotoxins | USP <85> | <1 EU/mL | Passed |
| Elemental Impurities | USP <232> / ICP-OES | Within Reported Acceptance Criteria | Passed |
This table is a summary only. Analytical reports, chromatograms, calibration data, microbiological records, and supporting laboratory documentation are included in the complete laboratory file.
Public Documentation
BAC Colombia publishes both a concise summary and the complete supporting laboratory file for the current production lot. The full file includes the analytical records provided with the laboratory review of Lot 005-2026.
Lot 005-2026
A concise overview of the reported laboratory results for the current production lot.
Lot 005-2026
The full documentation package supporting the analytical and microbiological review of the current production lot.
Independent Verification
Independent testing adds a separate layer of review beyond internal production records. Representative samples are submitted to an external laboratory so that reported characteristics can be assessed using documented analytical and microbiological methods.
Publishing the resulting reports allows customers, researchers, institutions, and procurement teams to review the same lot-specific information used to support the release of each BAC Colombia production batch.
Testing Overview
Each test contributes a different piece of information about the reported characteristics of the production lot. The sections below explain the purpose of the principal tests included in the current laboratory documentation.
Appearance testing is a visual evaluation of the submitted sample. The report for Lot 005-2026 describes the sample as clear and colorless.
pH testing measures the acidity or alkalinity of the submitted sample. Lot 005-2026 reported a measured pH of 6.87.
High-performance liquid chromatography (HPLC) was used to quantify benzyl alcohol in the submitted sample. Lot 005-2026 reported a measured concentration of 9.48 mg/mL.
Sterility testing evaluates submitted samples for detectable viable microbial growth under the conditions described in USP Chapter <71>. The report for Lot 005-2026 states no growth detected.
Bacterial endotoxin testing measures endotoxin levels in the submitted sample using the laboratory method referenced to USP Chapter <85>. Lot 005-2026 reported a result below 1 EU/mL.
Elemental analysis examines the submitted sample for selected elements using instrumental methods such as ICP-OES. The laboratory report states that Lot 005-2026 met the reported acceptance criteria for the tested elements.
The laboratory documentation for Lot 005-2026 applies to BAC Colombia 3 mL, 10 mL, and 30 mL presentations filled from the same production lot.
Testing is performed at the production-lot level using representative samples. Individual vial sizes are not tested as separate production lots when they originate from the same batch.
Frequently Asked Questions
The answers below explain how BAC Colombia organizes, publishes, and updates its lot-specific laboratory documentation.
BAC Colombia’s testing program is structured around lot-specific third-party laboratory analysis. Each released production lot receives its own supporting documentation.
A Certificate of Analysis, commonly called a COA, is a document that summarizes reported test results for a specific sample or production lot. It should be reviewed together with the applicable test methods, specifications, and supporting laboratory reports.
The three presentations are covered by the same documentation when they are filled from the same production lot. Testing is performed at the lot level using representative samples rather than treating each vial size as a separate batch.
Batch-level testing allows the reported analytical results to be tied to a specific production lot. Products originating from that lot can then be identified through the corresponding lot number and documentation.
The published documents identify the independent laboratory responsible for the reported testing. BAC Colombia provides the original supporting documentation received for the applicable production lot.
Yes. BAC Colombia publishes both a quick summary and the complete available laboratory file for the current production lot.
The complete file for Lot 005-2026 includes analytical reports and supporting records such as chromatograms, calibration information, and microbiological documentation where provided by the laboratory.
USP <71> refers to a United States Pharmacopeia chapter describing sterility test procedures. Referencing a USP chapter identifies the reported test method; it does not by itself indicate regulatory approval of a product.
USP <85> refers to bacterial endotoxin testing procedures described by the United States Pharmacopeia. The current report lists the method used and the result reported for Lot 005-2026.
High-performance liquid chromatography is an analytical technique used to separate, identify, and quantify compounds in a sample. The current documentation reports HPLC testing for benzyl alcohol quantification.
Inductively coupled plasma optical emission spectrometry is an instrumental technique used to measure selected elements in a sample. The full documentation identifies the reported elemental testing performed for the current lot.
Yes. As new production lots are released, BAC Colombia updates this page with the corresponding lot information and available supporting documents.
No. Laboratory results describe the submitted sample and the reported test outcomes. They do not constitute regulatory authorization or approval for human or veterinary use.
Documentation Philosophy
BAC Colombia believes customers should be able to review meaningful lot-specific documentation rather than rely only on general quality statements.
For this reason, we publish the current lot number, selected laboratory results, a concise summary, and the complete available supporting file. This allows visitors to review both the reported conclusions and the underlying documentation.
The documentation is updated when a new production lot becomes available so that product information remains connected to the applicable batch.
Explore BAC Colombia
View available 3 mL, 10 mL, and 30 mL presentations.
Review processing times and delivery estimates across Colombia.
Read important Research Use Only and regulatory information.
Contact our team with questions about products or documentation.
Product and Regulatory Notice: BAC Colombia products are offered for Research Use Only (RUO). The laboratory documentation published on this page is provided for transparency, product information, and lot-specific quality verification. Laboratory results relate to the submitted samples and do not constitute regulatory authorization, approval for human or veterinary use, or evidence of therapeutic suitability. BAC Colombia products offered for Research Use Only are not approved by INVIMA for human use.